Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Ginsenoside Rg3 may help hair growth by increasing a growth-related protein in hair cells.

Epidermal resident memory T cells play a crucial role in skin immunity and disease understanding.

People with acne have more CD4+ immune cells in their skin than healthy people.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Trichoepitheliomas and some basal cell carcinomas likely come from hair follicle stem cells.